Given this is a Director's award, I'd be remiss to ignore the broader context of what the current NIH Director is presiding over right now at the NIH. These were my full thoughts when asked for a quote for this piece on what this means to me and our lab.
This work was spearheaded by Brittany Johnson, the very first Meers Lab member who has now moved on to a PhD at @ibisatnu.bsky.social, with big assists from Gabe Boyle and @sarthylab.bsky.social at Seattle Children's and David Spencer here at WashU. Hoping this is the first of many for the lab! 3/3
Congrats Meers Lab! Very important to develop an affordable, high-throughput version of CUT&Tag and have interesting findings in AML!
Thank you @erikaberas.bsky.social for including me in this in depth @planetmoney.bsky.social piece on the mechanics of research funding at universities—I give it a 👍🏻👌👏👨🔬 emoji 🙃 www.npr.org/2025/05/28/1...
Please read our preprint: "G1 length dictates heterochromatin landscape"
www.biorxiv.org/content/10.1...
Fantastic (& open access!) review by Delaney, Weiss, & Almouzni out this week in Mol Cell: www.cell.com/molecular-ce...; a timely synthesis covering everything you might want to know about dynamic H3 variant deposition and recycling, but were too afraid to ask 😄
Really excited to have contributed (in minor part) to this study from the
@SarthyLab
on chromatin vulnerabilities in CBFA2T3-GLIS2 AMLs. A clever synthesis of chromatin profiling, single-cell RNA, and DepMap data to uncover both mechanism and target 1/6 www.biorxiv.org/content/10.1...
